Trial Profile
Carmustine implant (Gliadel Wafer) plus adjuvant and concomitant Temozolomide in combination with radiotherapy in primary glioblastoma patients.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 01 Aug 2011
Price :
$35
*
At a glance
- Drugs Carmustine (Primary) ; Temozolomide (Primary)
- Indications Glioblastoma
- Focus Therapeutic Use
- 01 Aug 2011 New trial record